HLA-DR expression (both frequency and MFI) significantly increased in RA patients after biologic therapy, irrespective of response to treatment (Fig 14), but no significant differences were observed in CXCR5 and IgM expression. This evidence concerns the gene CXCR5 and rheumatoid arthritis.